Search for: "Sandoz, Inc. "
Results 401 - 420
of 598
Sorted by Relevance
|
Sort by Date
5 Jan 2009, 6:32 pm
Affected by the FDA recall are Duragesic 50 mcg/hr patches in lot number 0817239 as are Sandoz Inc. 50 mcg/hr patches in lot number 0816851. [read post]
14 Nov 2016, 9:16 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
9 Mar 2016, 11:43 am
Sandoz, Inc., 135 S. [read post]
14 Dec 2009, 4:38 pm
Sandoz, Inc. [read post]
14 Mar 2014, 8:00 am
Sandoz, Inc., 13-854, a patent-infringement suit over a drug widely prescribed for treating multiple sclerosis, and a case so well-lawyered that Alan Dershowitz’s name appears on the brief’s inside cover. [read post]
28 Sep 2016, 8:39 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
13 Oct 2016, 6:50 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) BPCIA – Notice of Commercial Marketing: Sandoz Inc. v. [read post]
19 May 2010, 6:15 am
Immutopics, Inc. [read post]
23 Jan 2019, 8:23 am
” Gilead Scis., Inc. v. [read post]
19 Apr 2014, 8:50 am
On Good Friday, April 18, 2014, Chief Justice Roberts, denied Teva a request for a stay in the Copaxone case, noting that he was not convinced Teva had shown the "likelihood of irreparable harm" if the application was denied, because if Teva wins the Supreme Court case it can seek damages from the generic companies for past infringement on its patents.In this case, Teva, a known generic manufacturer, is in the role of proprietary drug maker, fighting the generic arm of a proprietary company… [read post]
31 Aug 2015, 7:52 am
See Litton Sys., Inc. v. [read post]
20 Jan 2015, 9:33 am
Sandoz, Inc. [read post]
31 Mar 2014, 6:56 am
ABC, Inc., v. [read post]
21 Jul 2010, 1:05 am
Lupin Pharmaceuticals, Inc (FDA Law Blog) Olux (Clobetasol) – Perrigo confirms patent challenge for Colobetasol propionate emulsion foam (GenericsWeb) Prandin (Repaglinide) – US: Actavis, Sandoz bring inequitable conduct counterclaims against Novo Nordisk in Prandin suit (Patent Docs) Protonix (Pantoprazole) – US: District Court New Jersey denies Teva’s motion to overturn jury verdict finding the patent in suit not invalid in Protonix litigation (SmartBrief)… [read post]
4 Feb 2015, 2:31 pm
” quoting Leapfrog Enters., Inc. v. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
27 Mar 2014, 6:07 am
Sandoz, Inc., 13-854, made it into the second round; the case raises the question whether a district court’s fact findings made in the course of patent interpretation should be reviewed de novo or for clear error. [read post]
14 Jul 2010, 6:47 pm
Anika Therapeutics, Inc. [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
8 Mar 2011, 1:23 pm
Sandoz, Inc., 566 F.3d 1282 (Fed. [read post]
